• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长因子HGF诱导上皮小管的形成依赖于STAT信号通路。

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway.

作者信息

Boccaccio C, Andò M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio P M

机构信息

Institute for Cancer Research, University of Torino Medical School, Candiolo, Italy.

出版信息

Nature. 1998 Jan 15;391(6664):285-8. doi: 10.1038/34657.

DOI:10.1038/34657
PMID:9440692
Abstract

Hepatocyte growth factor (HGF) induces a three-phase response leading to the formation of branched tubular structures in epithelial cells. The HGF receptor tyrosine kinase works through a Src homology (SH2) docking site that can activate several signalling pathways. The first phase of the response (scattering), which results from cytoskeletal reorganization, loss of intercellular junctions and cell migration, is dependent on phosphatidylinositol-3-OH kinase and Rac activation. The second phase (growth) requires stimulation of the Ras-MAP kinase cascade. Here we show that the third phase (tubulogenesis) is dependent on the STAT pathway. HGF stimulates recruitment of Stat-3 to the receptor, tyrosine phosphorylation, nuclear translocation and binding to the specific promoter element SIE. Electroporation of a tyrosine-phosphorylated peptide, which interferes with both the association of STAT to the receptor and STAT dimerization, inhibits tubule formation in vitro without affecting either HGF-induced 'scattering' or growth. The same result is obtained using a specific 'decoy' oligonucleotide that prevents STAT from binding to DNA and affecting the expression of genes involved in cell-cycle regulation (c-fos and waf-1). Activation of signal transducers that directly control transcription is therefore required for morphogenesis.

摘要

肝细胞生长因子(HGF)可诱导上皮细胞产生三相反应,最终形成分支管状结构。HGF受体酪氨酸激酶通过一个能激活多种信号通路的Src同源(SH2)对接位点发挥作用。反应的第一阶段(散射)是由细胞骨架重组、细胞间连接丧失和细胞迁移引起的,这一阶段依赖于磷脂酰肌醇-3-OH激酶和Rac激活。第二阶段(生长)需要刺激Ras-MAP激酶级联反应。我们在此表明,第三阶段(管状结构形成)依赖于STAT途径。HGF刺激Stat-3募集到受体上,使其酪氨酸磷酸化、发生核转位并与特定启动子元件SIE结合。电穿孔导入一种酪氨酸磷酸化肽,该肽可干扰STAT与受体的结合以及STAT二聚化,在不影响HGF诱导的“散射”或生长的情况下,抑制体外管状结构的形成。使用一种特异性“诱饵”寡核苷酸也可得到相同结果,该寡核苷酸可阻止STAT与DNA结合并影响参与细胞周期调控的基因(c-fos和waf-1)的表达。因此,形态发生需要直接控制转录的信号转导子的激活。

相似文献

1
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway.生长因子HGF诱导上皮小管的形成依赖于STAT信号通路。
Nature. 1998 Jan 15;391(6664):285-8. doi: 10.1038/34657.
2
Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.肝细胞生长因子/分散因子通过RAS-RAF-MEK-ERK信号通路激活ETS1转录因子。
Oncogene. 2002 Apr 4;21(15):2309-19. doi: 10.1038/sj.onc.1205297.
3
Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.Grb2在表皮生长因子信号传导中对Stat3激活起负向调节作用。
Biochem J. 2003 Dec 1;376(Pt 2):457-64. doi: 10.1042/BJ20030668.
4
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.受体酪氨酸激酶和细胞因子对Stat3的激活调节人非小细胞癌细胞的存活。
Oncogene. 2003 Jul 3;22(27):4150-65. doi: 10.1038/sj.onc.1206479.
5
HGF controls branched morphogenesis in tubular glands.肝细胞生长因子控制管状腺体的分支形态发生。
Eur J Morphol. 1998 Aug;36 Suppl:74-81.
6
Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis.HGF诱导的分支小管形成需要磷脂酶C-γ持续募集至Gab1。
Oncogene. 2000 Mar 16;19(12):1509-18. doi: 10.1038/sj.onc.1203514.
7
Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.肝细胞生长因子在肝细胞中Met-β-连环蛋白解离后诱导β-连环蛋白发生不依赖Wnt的核转位。
Cancer Res. 2002 Apr 1;62(7):2064-71.
8
Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.内皮细胞受体酪氨酸激酶激活STAT信号通路:导致静脉畸形的突变型Tie-2发出独特的STAT激活反应信号。
Oncogene. 1999 Jan 7;18(1):1-8. doi: 10.1038/sj.onc.1202288.
9
MAP kinase and beta-catenin signaling in HGF induced RPE migration.肝细胞生长因子诱导视网膜色素上皮细胞迁移过程中的丝裂原活化蛋白激酶和β-连环蛋白信号传导
Mol Vis. 2002 Dec 20;8:483-93.
10
Activation of the Jak-STAT-signaling pathway in embryonic lens cells.胚胎晶状体细胞中Jak-STAT信号通路的激活。
Dev Biol. 1998 Dec 1;204(1):277-92. doi: 10.1006/dbio.1998.9077.

引用本文的文献

1
Management of MET-Driven Resistance to Osimertinib in -Mutant Non-Small Cell Lung Cancer.MET驱动的EGFR突变型非小细胞肺癌对奥希替尼耐药的管理
Genes (Basel). 2025 Jun 30;16(7):772. doi: 10.3390/genes16070772.
2
Evolving roles of MET as a therapeutic target in NSCLC and beyond.MET作为非小细胞肺癌及其他疾病治疗靶点的角色演变。
Nat Rev Clin Oncol. 2025 Jul 18. doi: 10.1038/s41571-025-01051-9.
3
Induced pluripotent stem cell-derived stellate cells promote proliferation of induced pluripotent stem cell-derived hepatocytes through the mitogen-activated protein kinase pathway via hepatocyte growth factor.
诱导多能干细胞来源的星状细胞通过肝细胞生长因子经丝裂原活化蛋白激酶途径促进诱导多能干细胞来源的肝细胞增殖。
Surg Today. 2025 May 17. doi: 10.1007/s00595-025-03061-7.
4
MET Activation in Lung Cancer and Response to Targeted Therapies.肺癌中的MET激活与靶向治疗反应
Cancers (Basel). 2025 Jan 16;17(2):281. doi: 10.3390/cancers17020281.
5
Epithelial tubule interconnection driven by HGF-Met signaling in the kidney.肾中由肝细胞生长因子-间质-上皮转化因子信号传导驱动的上皮小管互连。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2416887121. doi: 10.1073/pnas.2416887121. Epub 2024 Dec 20.
6
Epithelial tubule interconnection driven by HGF-Met signaling in the kidney.由肾脏中肝细胞生长因子-间质-上皮转化因子信号驱动的上皮小管互连。
bioRxiv. 2024 Jun 3:2024.06.03.597185. doi: 10.1101/2024.06.03.597185.
7
Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells.在 HCT116 结直肠癌细胞中通过分选连接蛋白 1/2 对肝细胞生长因子受体 MET 活性进行时空调节。
Biosci Rep. 2024 Jun 26;44(6). doi: 10.1042/BSR20240182.
8
The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy.MET原癌基因:对驱动恶性肿瘤的分子机制三十年的洞察
Pharmaceuticals (Basel). 2024 Mar 30;17(4):448. doi: 10.3390/ph17040448.
9
Metabolic alterations in hereditary and sporadic renal cell carcinoma.遗传性和散发性肾细胞癌的代谢改变。
Nat Rev Nephrol. 2024 Apr;20(4):233-250. doi: 10.1038/s41581-023-00800-2. Epub 2024 Jan 22.
10
An Observatory for the Oncogene: A Guide for Targeted Therapies.癌基因观察站:靶向治疗指南
Cancers (Basel). 2023 Sep 21;15(18):4672. doi: 10.3390/cancers15184672.